Sublocade® is a new medication alternative for treating opioid addiction. It is an injectable form of buprenorphine that should be used as part of a complete treatment plan that includes counseling. The injection is subcutaneous (under the skin). The medication gradually breaks down (biodegrades) and releases buprenorphine for 30 days so that opioid withdrawal symptoms are effectively managed. It is recommended that Sublocade® only be offered to patients who have been receiving a consistent dose of buprenorphine and are otherwise stable in their recovery.
CATC currently only offers Sublocade® in select Treatment Centres, please contact us for more information.